Earnings Feed
Start Free
Home/Filings/4/0001177648-18-000038
4//SEC Filing

Ocain Tim 4

Accession 0001177648-18-000038

CIK 0001177648other
View on SEC.govCompany Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:22 PM ET

Size

17.4 KB

Accession

0001177648-18-000038

Insider Transaction Report

Form 4
Period: 2018-10-01
ENANTA PHARMACEUTICALS INCENTA
Ocain Tim
Senior Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2018-10-01$32.27/sh+10,000$322,700→ 31,127 total
  • Sale

    Common Stock

    2018-10-01$82.04/sh−3,500$287,142→ 27,627 total
  • Sale

    Common Stock

    2018-10-01$83.47/sh−6,219$519,127→ 21,408 total
  • Sale

    Common Stock

    2018-10-01$84.02/sh−14,677$1,233,113→ 6,731 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-10-01−15,000→ 0 total
    Exercise: $19.98Exp: 2023-10-29→ Common Stock (15,000 underlying)
  • Exercise/Conversion

    Common Stock

    2018-10-01$19.98/sh+15,000$299,700→ 21,127 total
  • Sale

    Common Stock

    2018-10-01$85.30/sh−604$51,521→ 6,127 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-10-01−10,000→ 60,000 total
    Exercise: $32.27Exp: 2024-01-30→ Common Stock (10,000 underlying)
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $81.84 to $82.21, inclusive.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $82.77 to $83.76, inclusive.
  • [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.77 to $84.73, inclusive.
  • [F5]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.915 to $85.67, inclusive.
  • [F6]100% of the shares subject to this option are fully vested and exercisable.

Documents

1 file

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

→
Entity typeother

Related Parties

1
  • filerCIK 0001599020

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:22 PM ET
Size
17.4 KB
View on SEC.gov